Metabolic rhythm abnormalities in mice lacking VIP-VPAC2 signaling

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 2, 2008, Pages

  Bechtold, David A ^a   Brown, Timothy M ^a   Luckman, Simon M ^a   Piggins, Hugh D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Circadian; Diurnal; Suprachiasmatic; Vasoactive intestinal polypeptide; VPAC2 receptor

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEEDING BEHAVIOR; HORMONE DEFICIENCY; KNOCKOUT MOUSE; MALE; METABOLIC DISORDER; METABOLIC RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; BASAL METABOLISM; CIRCADIAN RHYTHM; FEEDING BEHAVIOR; LIGHTING; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 38949212500     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00667.2007     Document Type: Article

References (37)

1. Alexander LD, Evans K, Sander LD. A possible involvement of VIP in feeding-induced secretion of ACTH and corticosterone in the rat. Physiol Behav 58: 409-413, 1995.
2. Aton SJ, Colwell CS, Harmar AJ, Waschek J, Herzog ED. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci 8: 476-483, 2005.
3. Brown TM, Colwell CS, Waschek JA, Piggins HD. Disrupted neuronal activity rhythms in the suprachiasmatic nuclei of vasoactive intestinal polypeptide-deficient mice. J Neurophysiol 97: 2553-2558, 2007.
4. Brown TM, Hughes AT, Piggins HD. Gastrin-releasing peptide promotes suprachiasmatic nuclei cellular rhythmicity in the absence of vasoactive intestinal polypeptide-VPAC2 receptor signaling. J Neurosci 25: 11155-11164, 2005.
5. Chance WT, Thompson H, Thomas I, Fischer JE. Anorectic and neurochemical effects of pituitary adenylate cyclase activating polypeptide in rats. Peptides 16: 1511-1516, 1995.
6. Colwell CS, Michel S, Itri J, Rodriguez W, Tam J, Lelievre V, Hu Z, Liu X, Waschek JA. Disrupted circadian rhythms in VIP- and PHI-deficient mice. Am J Physiol Regul Integr Comp Physiol 285: R939-R949, 2003.
7. Cutler DJ, Haraura M, Reed HE, Shen S, Sheward WJ, Morrison CF, Marston HM, Harmar AJ, Piggins HD. The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro. Eur J Neurosci 17: 197-204, 2003.
8. Guilding C, Piggins HD. Challenging the omnipotence of the suprachiasmatic timekeeper: are circadian oscillators present throughout the mammalian brain? Eur J Neurosci 25: 3195-3216, 2007.
9. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA. International Union of Pharmacology. XVIII Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50: 265-270, 1998.
10. Harmar AJ, Marston HM, Shen S, Spratt C, West KM, Sheward WJ, Morrison CF, Dorin JR, Piggins HD, Reubi JC, Kelly JS, Maywood ES, Hastings MH. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell 109: 497-508, 2002.
11. Harmar AJ, Sheward WJ, Morrison CF, Waser B, Gugger M, Reubi JC. Distribution of the VPAC2 receptor in peripheral tissues of the mouse. Endocrinology 145: 1203-1210, 2004.
12. Hastings MH, Reddy AB, Garabette M, King VM, Chahad-Ehlers S, O'Brien J, Maywood ES. Expression of clock gene products in the suprachiasmatic nucleus in relation to circadian behaviour. Novartis Found Symp 253: 203-217; discussion 102-209, 218-222, 281-204, 2003.
13. Hughes AT, Fahey B, Cutler DJ, Coogan AN, Piggins HD. Aberrant gating of photic input to the suprachiasmatic circadian pacemaker of mice lacking the VPAC2 receptor. J Neurosci 24: 3522-3526, 2004.
14. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Hum Mol Genet 2: R271-R277, 2006.
15. Kulkosky PJ, Doyle JS, Cook VI, Glazner GW, Foderaro MA. Vasoactive intestinal peptide: behavioral effects in the rat and hamster. Pharmacol Biochem Behav 34: 387-393, 1989.
16. Laposky AD, Bass J, Kohsaka A, Turek FW. Sleep and circadian rhythms: Key components in the regulation of energy metabolism. FEBS Lett In press.
17. Loren I, Tornqvist K, Alumets J. VIP (vasoactive intestinal polypeptide)-immunoreactive neurons in the retina of the rat. Cell Tissue Res 210: 167-170, 1980.
18. Maywood ES, Reddy AB, Wong GK, O'Neill JS, O'Brien JA, McMahon DG, Harmar AJ, Okamura H, Hastings MH. Synchronization and maintenance of timekeeping in suprachiasmatic circadian clock cells by neuropeptidergic signaling. Curr Biol 16: 599-605, 2006.
19. Mizuno Y, Kondo K, Terashima Y, Arima H, Murase T, Oiso Y. Anorectic effect of pituitary adenylate cyclase activating polypeptide (PACAP) in rats: lack of evidence for involvement of hypothalamic neuropeptide gene expression. J Neuroendocrinol 10: 611-616, 1998.
20. Morley JE, Horowitz M, Morley PM, Flood JF. Pituitary adenylate cyclase activating polypeptide (PACAP) reduces food intake in mice. Peptides 13: 1133-1135, 1992.
21. Mrosovsky N. Locomotor activity and non-photic influences on circadian clocks. Biol Rev Camb Philos Soc 71: 343-372, 1996.
22. Nakata M, Kohno D, Shintani N, Nemoto Y, Hashimoto H, Baba A, Yada T. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus. Neurosci Lett 370: 252-256, 2004.
23. Piggins HD. Human clock genes. Ann Med 34: 394-400, 2002.
24. Piggins HD, Antle MC, Rusak B. Neuropeptides phase shift the mammalian circadian pacemaker. J Neurosci 15: 5612-5622, 1995.
25. Piggins HD, Cutler DJ. The roles of vasoactive intestinal polypeptide in the mammalian circadian clock. J Endocrinol 177: 7-15, 2003.
26. Ralph MR, Foster RG, Davis FC, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science 247: 975-978, 1990.
27. Reed HE, Meyer-Spasche A, Cutler DJ, Coen CW, Piggins HD. Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus clock in vitro. Eur J Neurosci 13: 839-843, 2001.
28. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 418: 935-941, 2002.
29. Rudic RD, McNamara P, Curtis AM, Boston RC, Panda S, Hogenesch JB, Fitzgerald GA. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol 2: e377, 2004.
30. Rusak B, Zucker I. Neural regulation of circadian rhythms. Physiol Rev 59: 449-526, 1979.
31. Schibler U. Circadian time keeping: the daily ups and downs of genes, cells, and organisms. Prog Brain Res 153: 271-282, 2006.
32. Sheward WJ, Maywood ES, French KL, Horn JM, Hastings MH, Seckl JR, Holmes MC, Harmar AJ. Entrainment to feeding but not to light: circadian phenotype of VPAC2 receptor-null mice. J Neurosci 27: 4351-4358, 2007.
33. Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, Laposky A, Losee-Olson S, Easton A, Jensen DR, Eckel RH, Takahashi JS, Bass J. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308: 1043-1045, 2005.
34. Vosko AM, Schroeder A, Loh DH, Colwell CS. Vasoactive intestinal peptide and the mammalian circadian system. Gen Comp Endocrinol 152: 165-175, 2007.
35. Wijnen H, Young MW. Interplay of circadian clocks and metabolic rhythms. Annu Rev Genet 40: 409-448, 2006.
36. Woods SC, West DB, Stein LJ, McKay LD, Lotter EC, Porte SG, Kenney NJ, Porte D Jr. Peptides and the control of meal size. Diabetologia Suppl 20: 305-313, 1981.
37. Yamaguchi S, Isejima H, Matsuo T, Okura R, Yagita K, Kobayashi M, Okamura H. Synchronization of cellular clocks in the suprachiasmatic nucleus. Science 302: 1408-1412, 2003.